IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
- PMID: 23160470
- DOI: 10.1182/blood-2012-05-431718
IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
Abstract
Long-living memory stem T cells (T(SCM)) with the ability to self-renew and the plasticity to differentiate into potent effectors could be valuable weapons in adoptive T-cell therapy against cancer. Nonetheless, procedures to specifically target this T-cell population remain elusive. Here, we show that it is possible to differentiate in vitro, expand, and gene modify in clinically compliant conditions CD8(+) T(SCM) lymphocytes starting from naive precursors. Requirements for the generation of this T-cell subset, described as CD62L(+)CCR7(+)CD45RA(+)CD45R0(+)IL-7Rα(+)CD95(+), are CD3/CD28 engagement and culture with IL-7 and IL-15. Accordingly, T(SCM) accumulates early after hematopoietic stem cell transplantation. The gene expression signature and functional phenotype define this population as a distinct memory T-lymphocyte subset, intermediate between naive and central memory cells. When transplanted in immunodeficient mice, gene-modified naive-derived T(SCM) prove superior to other memory lymphocytes for the ability to expand and differentiate into effectors able to mediate a potent xenogeneic GVHD. Furthermore, gene-modified T(SCM) are the only T-cell subset able to expand and mediate GVHD on serial transplantation, suggesting self-renewal capacity in a clinically relevant setting. These findings provide novel insights into the origin and requirements for T(SCM) generation and pave the way for their clinical rapid exploitation in adoptive cell therapy.
Comment in
-
Moving T memory stem cells to the clinic.Blood. 2013 Jan 24;121(4):567-8. doi: 10.1182/blood-2012-11-468660. Blood. 2013. PMID: 23349370 No abstract available.
Similar articles
-
Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency.J Immunol. 2015 Jun 1;194(11):5559-67. doi: 10.4049/jimmunol.1402090. Epub 2015 Apr 27. J Immunol. 2015. PMID: 25917088
-
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes.Blood. 2009 Jan 29;113(5):1006-15. doi: 10.1182/blood-2008-05-156059. Epub 2008 Oct 31. Blood. 2009. PMID: 18978209
-
Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale.J Immunother. 2012 Nov-Dec;35(9):689-701. doi: 10.1097/CJI.0b013e318270dec7. J Immunother. 2012. PMID: 23090078 Free PMC article.
-
Decisions on the road to memory.Adv Exp Med Biol. 2013;785:107-20. doi: 10.1007/978-1-4614-6217-0_12. Adv Exp Med Biol. 2013. PMID: 23456843 Review.
-
Homeostasis of naive and memory T cells.Immunity. 2008 Dec 19;29(6):848-62. doi: 10.1016/j.immuni.2008.11.002. Immunity. 2008. PMID: 19100699 Review.
Cited by
-
A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.J Transl Med. 2016 Jul 19;14(1):214. doi: 10.1186/s12967-016-0973-y. J Transl Med. 2016. PMID: 27435312 Free PMC article.
-
EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma.Int J Med Sci. 2020 Jun 5;17(10):1406-1414. doi: 10.7150/ijms.45603. eCollection 2020. Int J Med Sci. 2020. PMID: 32624697 Free PMC article.
-
Naive CD8+ T Cells Expressing CD95 Increase Human Cardiovascular Disease Severity.Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2845-2859. doi: 10.1161/ATVBAHA.120.315106. Epub 2020 Oct 15. Arterioscler Thromb Vasc Biol. 2020. PMID: 33054398 Free PMC article.
-
Harnessing the tumor microenvironment to boost adoptive T cell therapy with engineered lymphocytes for solid tumors.Semin Immunopathol. 2024 Jul 25;46(3-4):8. doi: 10.1007/s00281-024-01011-y. Semin Immunopathol. 2024. PMID: 39060547 Review.
-
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes.Mol Cancer. 2024 Sep 9;23(1):193. doi: 10.1186/s12943-024-02104-w. Mol Cancer. 2024. PMID: 39251981 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials